Alaunos Therapeutics, Inc. (TCRT) Net income 2016–2025
Alaunos Therapeutics, Inc. (TCRT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$4.2MFY2025 · since FY2016: -$165.3M → -$4.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.2M | +10.8% |
| FY2024 | -$4.7M | +0.0% |
| FY2023 | -$4.7M | +87.6% |
| FY2022 | -$37.7M | +52.1% |
| FY2021 | -$78.8M | +1.5% |
| FY2020 | -$80.0M | +32.1% |
| FY2019 | -$117.8M | -121.8% |
| FY2018 | -$53.1M | +2.2% |
| FY2017 | -$54.3M | +67.1% |
| FY2016 | -$165.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice